EUVIMEDOpdag EUVIMED
Crossref

Spectroscopic characterization and pharmacokinetic evaluation of amorphous solid dispersions of glibenclamide for bioavailability enhancement in Wistar rats

Khalid Bashir Mir iD, Vidushi Abrol, Nasseb Singh, Nisar A Khan, Alamgir A Dar iD, Tahani Awad Alahmadi, Mohammad Javed Ansari

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5901 ↗

At a glance

Journal article in Biomedical Chromatography, 2024. Written by Khalid Bashir Mir and 6 co-authors. Institution: School of Medical and Allied Sciences, K. R. Mangalam University, Gurgaon, Haryana, India. Major MEDLINE topics: Glyburide, Rats, Wistar, Biological Availability, Poloxamer. 41 references. Funded by: King Saud University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Oral bioavailability of glibenclamide (Glb) was appreciably improved by the formation of an amorphous solid dispersion with Poloxamer‐188 (P‐188). Poloxamer‐188 substantially enhanced the solubility and thereby the dissolution rate of the biopharmaceutics classification system (BCS) class II drug Glb and simultaneously exhibited a better stabilizing effect of the amorphous solid dispersion prepared by the solvent evaporation method. The physical state of the dispersed Glb in the polymeric matrix was characterized by differential scanning calorimetry, X‐ray diffraction, scanning electron microscope and Fourier transform infrared studies. In vitro drug release in buffer (pH 7.2) revealed that the amorphous solid dispersion at a Glb–P‐188 ratio of 1:6 (SDE 4 ) improved the dissolution of Glb by 90% within 3 h. A pharmacokinetic study of the solid dispersion formulation SDE 4 in Wistar rats showed that the oral bioavailability of the drug was greatly increased as compared with the market tablet formulation, Daonil®. The formulation SDE 4 resulted in an AUC 0–24h ~2‐fold higher. The SDE 4 formulation was found to be stable during the study period of 6 months.

Subjects

MeSH terms (MEDLINE)

GlyburideRats, WistarBiological AvailabilityPoloxamerAnimalsRatsMaleDrug StabilitySpectroscopy, Fourier Transform InfraredX-Ray DiffractionCalorimetry, Differential ScanningSolubility

Author keywords

FT‐IRPoloxamer‐188glibenclamidepharmacokineticsphysical mixturesolid dispersion

Substances

GlyburidePoloxamer

Authors and institutions

  • School of Medical and Allied Sciences, K. R. Mangalam University, Gurgaon, Haryana, India.
  • Fermentation and Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Jammu Tawi, India.
  • Synthetic Organic Chemistry Laboratory, Faculty of Sciences, Shri Mata Vaishno Devi University, Katra, India.
  • Department of Chemistry, Govt. Gandhi Memorial Science College Jammu (a Constituent College of Cluster University of Jammu), Jammu and Kashmir, India.
  • Department of Pharmaceutical Sciences, University of Kashmir Srinagar, Jammu and Kashmir, India.
  • Research Centre for Residue and Quality Analysis, Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir, Shalimar, Jammu and Kashmir, Srinagar, India.

ORCID profiles: Khalid Bashir Mir, Alamgir A Dar

Funding

  • King Saud University

Cite

APA

Mir, K. B., Abrol, V., Singh, N., Khan, N. A., Dar, A. A., Alahmadi, T. A., & Ansari, M. J. (2024). Spectroscopic characterization and pharmacokinetic evaluation of amorphous solid dispersions of glibenclamide for bioavailability enhancement in Wistar rats. Biomedical Chromatography. https://doi.org/10.1002/bmc.5901

Vancouver

Mir KB, Abrol V, Singh N, Khan NA, Dar AA, Alahmadi TA, et al. Spectroscopic characterization and pharmacokinetic evaluation of amorphous solid dispersions of glibenclamide for bioavailability enhancement in Wistar rats. Biomedical Chromatography. 2024. doi:10.1002/bmc.5901

BibTeX
@article{Mir2024,
  author = {Mir, Khalid Bashir and Abrol, Vidushi and Singh, Nasseb and Khan, Nisar A and Dar, Alamgir A and Alahmadi, Tahani Awad and Ansari, Mohammad Javed},
  title = {Spectroscopic characterization and pharmacokinetic evaluation of amorphous solid dispersions of glibenclamide for bioavailability enhancement in Wistar rats},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5901}
}
Start for free →